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The p66Shc Adaptor Protein Controls Oxidative Stress
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Abstract
The in vitro production of mammalian embryos suffers from high frequencies of developmental failure due to excessive
levels of permanent embryo arrest and apoptosis caused by oxidative stress. The p66Shc stress adaptor protein controls
oxidative stress response of somatic cells by regulating intracellular ROS levels through multiple pathways, including
mitochondrial ROS generation and the repression of antioxidant gene expression. We have previously demonstrated a
strong relationship with elevated p66Shc levels, reduced antioxidant levels and greater intracellular ROS generation with
the high incidence of permanent cell cycle arrest of 2–4 cell embryos cultured under high oxygen tensions or after oxidant
treatment. The main objective of this study was to establish a functional role for p66Shc in regulating the oxidative stress
response during early embryo development. Using RNA interference in bovine zygotes we show that p66Shc knockdown
embryos exhibited increased MnSOD levels, reduced intracellular ROS and DNA damage that resulted in a greater
propensity for development to the blastocyst stage. P66Shc knockdown embryos were stress resistant exhibiting
significantly reduced intracellular ROS levels, DNA damage, permanent 2–4 cell embryo arrest and diminished apoptosis
frequencies after oxidant treatment. The results of this study demonstrate that p66Shc controls the oxidative stress
response in early mammalian embryos. Small molecule inhibition of p66Shc may be a viable clinical therapy to increase the
developmental potential of in vitro produced mammalian embryos.
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in humans [15–19]. In vitro culture promotes excessive reactive
oxygen species (ROS) production that can override an embryo’s
antioxidant defenses producing oxidative stress that triggers
apoptosis, necrosis and/or permanent cell cycle arrest in the
developing early embryo [6,12,20,21]. Embryos deemed to have a
low developmental potential of reaching the blastocyst stage in vitro
generate significantly elevated levels of intracellular ROS
compared to embryos that have a greater tendency for blastocyst
formation [22]. Culture regimes utilizing reduced oxygen concentrations [16,23–25] or antioxidant supplementation [24,26,27]
have improved blastocyst development by reducing intracellular
ROS production [28,29].
We have begun to examine the biochemical and molecular
pathway(s) that characterize and control cellular redox state in
early embryos. Firstly, the early embryo response to ROS is
developmentally regulated [27]. Endogenously generated ROS
and/or exogenous ROS treatment elicits a dose-dependent,
detrimental effect on early development triggering either permanent embryo arrest (a senescence-like event) or apoptosis
depending on the preimplantation stage exposed to the oxidative
stress [12,20,27,29]. Conversely, antioxidant enzyme supplementation of the culture medium can limitedly reduce ROS-induced
developmental failures [29] suggesting that an optimum redox
state is required for proper embryo development. We have

Introduction
Assisted reproductive technologies (ART) involving the in vitro
production of preimplantation stage embryos are imperative for
the treatment of infertility and/or for fertility management in both
human and veterinary reproductive medicine [1,2]. As of 2012,
the number of ART babies born has reached an estimated 5
million since the world’s first, Louise Brown, who was born in July
1978 [3]. Similarily, the total number of in vitro produced (IVP)
bovine embryos transferred to recipients worldwide in 2011 alone
was 373,836 [4]. Despite this widespread use, the fertilization and
culturing of early human and livestock embryos in suboptimal,
foreign microenvironments leads to a high frequency (50–70%) of
early embryonic demise during this 5–7 days of in vitro development [5–8]. This high incidence of developmental failure has been
attributed to a wide range of non mutually exclusive dysfunctions
including poor gamete quality [9], chromosomal abnormalities
[10], telomere uncapping [11,12], and suboptimal culture
conditions that induce oxidative stress [13,14].
Numerous studies in many animals including livestock species
such as cattle have demonstrated the detrimental effects of
culturing gametes and embryos in non-physiological culture
systems and are considered valuable models for developing
reproductive biotechnologies and evaluating the effects of ART
PLOS ONE | www.plosone.org
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Injection pressure: 75 hPa; Constant pressure: 15 hPa; Injection
time: 0.1 sec; Calculated injection volume: 10 pL. To ensure the
effective transfer of fluid at the established regiment of pressure/
volume settings, groups (n = 75/r, r = 3) of embryos were injected
with a FITC-labeled oligonucleotide probe (Supplemental Table
S2). Following the injection protocol, a very high proportion
(95.3% 62.9%) of embryos showed intercellular fluorescence,
whereas a liposome-based approached failed (Supplemental Figure
S1).
To determine the optimum injection concentration of p66Shcspecific siRNAs, groups (n = 50/r, r = 3) of zygotes were injected
with a titration series (non-injected controls, 0.005, 0.05, 0.5, and
5.0 mM) of the p66Shc-specific siRNA molecule RNAi-E and
cultured to the 2–4 cell stage (48 hpi) before being pooled and
harvested for total RNA and reverse transcription. The 0.005 mM
p66Shc siRNA dose did not significantly (P.0.05) reduce p66Shc
mRNA (2.9060.1761026 pg) compared to embryos injected with
negative control siRNA molecules (3.1960.4561026 pg)
(Figure 1A). The remaining doses each produced significant
(P,0.05) decreases in endogenous p66Shc mRNA levels, with the
0.5 and 5.0 mM groups exhibiting the greatest reduction
(0.3260.2461026 pg; and 0.2060.2161026 pg respectively).
Overall, compared to p66Shc mRNA levels in control embryos
the 0.005 mM siRNA dose resulted in a 9.1% reduction, the
0.05 mM dose resulted in a 53.1% reduction, the 0.5 mM dose
resulted in a 90.3% reduction, and the 5.0 mM dose resulted in a
93.8% reduction in p66Shc mRNA abundance. Based on the
results of this trial it was determined that the 5.0 mM was the most
effective treatment. Histone H2A mRNA, which was quantified in
parallel as a control, showed no significant (P.0.05) differences
between treatment groups (Figure 1B).

identified the stress adaptor protein p66Shc as a major regulator of
cellular redox state in early embryos [22]. The reduced
developmental potential of embryos is associated with lower levels
of antioxidants and elevated quantities of intracellular ROS
generation, DNA damage and activated p66Shc [22,28,29]. Levels
of p66Shc are increased by high atmospheric oxygen or exogenous
ROS treatments and are significantly diminished by low oxygen
tension or catalase supplementation of the embryo culture media
[29]. RNA interference-mediated knockdown of p66Shc in
immature bovine oocytes before in vitro fertilization (IVF) significantly decreased the incidence of permanent embryo arrest,
however embryo development to the blastocyst stage was reduced
as well [30]. These results suggest that p66Shc mediates early
cleavage arrest but is also important for other later events during
the preimplantation period.
P66Shc is a 66-kDa Src collagen homologue (Shc) adaptor
protein that is one of three main isoforms encoded by the SHC1
gene (p46Shc, p52Shc, p66Shc) [31]. While p46Shc and p52Shc
isoforms link activated receptor tyrosine kinases to the Ras
pathway by recruitment of the GRB2/SOS complex [32,33],
p66Shc inhibits Ras signaling in response to epidermal growth
factor (EGF) [31]. P66Shc also mediates an inhibitory signaling
effect on the extracellular signal-regulated kinase (ERK) pathway
that is required for actin cytoskeleton polymerization [34] and
normal glucose transport control [33,35]. The p66Shc isoform is
also involved in signal pathways that regulate the cellular response
to oxidative stress and life span. Through phosphorylation of
Serine 36 in its unique N-terminal collagen homology-2 (CH2)
domain, p66Shc acts as a downstream target of the tumor
suppressor p53 and is essential for the ability of stress-activated
p53 to trigger intracellular ROS generation, cytochrome c release,
forkhead inactivation and apoptosis [36–39]. P66Shc knockout
mice exhibit increased longevity due to their resistance to oxidative
stress-induced DNA damage, apoptosis and disease [36,40–42].
Herein this study we examined the mechanistic role of p66Shc
in controlling the oxidative stress response of early preimplantation
stage embryos. Utilizing RNA interference (RNAi)-mediated
knockdown of p66Shc in bovine zygotes, we demonstrate that
p66Shc regulates intracellular ROS-induced DNA damage that
leads to permanent embryo arrest and apoptosis. P66Shc
knockdown embryos are stress resistant exhibiting reduced
intracellular ROS levels, diminished DNA damage and reduced
incidence of developmental failure leading to significantly
increased blastocyst frequencies during in vitro embryo development.

RNAi-mediated Knockdown of p66Shc in Early Bovine
Embryos
To verify the specificity of RNAi-mediated p66Shc knockdown
in bovine embryos, groups (n = 50/r, r = 3) of zygotes were
injected with two different, non-overlapping siRNA molecules
targeting p66Shc mRNA. Zygotes were either non-injected or
injected with 10 pL (5.0 mM) of either negative control siRNAs, or
one of two p66Shc-specific siRNAs (RNAi-A or RNAi-E).
Embryos were cultured to the 2–4 cell stage (32 hpi) before being
pooled and processed for total RNA extraction for p66Shc mRNA
quantification by Real Time PCR (Figure 1C). Histone H2A
mRNA, which was quantified in parallel as siRNA specificity and
PCR efficiency controls during this experiment, showed no
significant (P.0.05) differences between any experimental groups
(Figure 1D). The group of embryos injected with negative siRNA
(3.9060.2261026 pg) exhibited significantly (P,0.05) higher
levels of p66Shc mRNA than non-injected controls
(3.0760.3361026 pg). Although both anti-p66Shc siRNA molecules produced a significant (P,0.05) decrease in p66Shc mRNA
abundance, RNAi-E (0.2960.2161026 pg; 92.6% decrease vs.
negative siRNA control) generated a significantly greater reduction than RNAi-A (1.0760.3361026 pg; 72.6% decrease vs.
negative siRNA control). The results from this experiment indicate
that while RNAi-A and RNAi-E both effectively knockdown the
expression of p66Shc mRNA, RNAi-E was the most effective antip66Shc siRNA molecule and was utilized in the majority of the
experiments outlined. Initially, we employed both RNAi-A and
RNAi-E molecules to ascertain any developmental/physiological
differences caused by varying p66Shc knockdown efficiencies, but
after observing no significant differences (P.0.05; see below)
between the molecules we conducted further experiments with
only the more robust p66Shc-specific siRNA molecule (RNAi-E).

Results
Optimization of siRNA Delivery into Bovine Zygotes
To optimize the delivery of siRNA molecules into zygotes and
to evaluate the effects of microinjection on embryo development,
zygotes (sample size (n) = 50/replicate (r), r = 3) were injected with
a titration series (10 pL, 50 pL, 75 pL) of injection volumes
through the modulation of injection pressure and assessed for
cleavage division at 32 hpi (Supplemental Table S1). Constant
pressure was maintained throughout these experiments at the
lowest possible setting, which was found to maintain equilibrium
between excessive backflow and seepage. Increasing injection
volume was found to negatively correlate with successful cleavage
with the maximal volume resulting in the lowest rate of cleavage
(54.564.1%) while the minimal volume (representing the lower
limit of the FemtoJetTM Injection System) resulted in the highest
rate of cleavage (82.163.2%). The following regiment of injection
settings was established based on the results of this experiment:
PLOS ONE | www.plosone.org
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Figure 1. Real-time PCR quantification of p66Shc mRNA levels following RNAi-mediated knockdown of p66Shc in early bovine
embryos. Total RNA was extracted from pooled groups of 2–4 cell embryos that, at the zygote stage, were either non-injected, injected with
negative control short interfering (si)RNAs, or injected with the p66Shc-specific siRNA molecules (RNAi-A or RNAi-E). (A) Real-time PCR quantification
of p66Shc mRNA levels following a titration series of short interfering (si)RNAi-E molecules. The decrease in p66Shc mRNA levels became significant
by the 0.05 mM dose level. (B) Histone H2A mRNA was quantified in parallel as an internal control of PCR efficiency. (C) Embryos injected with
negative siRNA exhibited significantly higher levels of p66Shc mRNA than non-injected controls. Embryos injected with either RNAi-A or RNAi-E
molecules exhibited significantly decreased abundance in p66Shc mRNA. The reduction induced by the RNAi-E molecule was significantly greater
than that of the RNAi-A molecule. (D) Histone H2A mRNA was quantified in parallel as a control of PCR efficiency. Different letters above the
histogram bars represent significant differences (P,0.05) in transcript abundance. No significant differences in H2A mRNA were noted between
groups.
doi:10.1371/journal.pone.0086978.g001

To assess the duration of p66Shc knockdown during early
bovine development, groups (total n = 50/r, r = 3) of zygotes were
injected with 10 pL (5.0 mM) of either negative control siRNAs or
p66Shc-specific siRNA molecule RNAi-E and cultured until IVC
day 8 (192 hpi). Subgroups (n = 50) were sampled from each group
at the 2–4 cell (32 hpi), 9–16 cell (72 hpi), and blastocyst stage
(192 hpi). Each subgroup was processed for total RNA extraction
for Real Time PCR quantification of p66Shc mRNA levels
(Supplemental Figure S2). Histone H2A mRNA was quantified in
parallel as a control during this experiment and showed no
significant (P.0.05) differences between treatment groups (Supplemental Figure S2). Knockdown of p66Shc mRNA was greatest
(P,0.05)
at
the
2–4
cell
stage
(negative
siRNA = 3.2060.2161026 pg; RNAi-E = 0.3360.2561026 pg), representing an 89.7% decrease compared to control siRNA injected
embryos. By the 9–16 cell stage the difference between the p66Shc
and control siRNA group had diminished but remained significantly different (P,0.05; negative siRNA = 2.0960.2761026 pg;
RNAi-E = 0.7860.2261026 pg) at a 62.9% decrease compared to
controls. No significant difference (P.0.05) in p66Shc mRNA
abundance was observed between the two groups by the blastocyst
stage of development.

To confirm p66Shc protein levels after p66Shc knockdown,
groups (n = 50/r, r = 3) of zygotes were either non-injected or
injected with 10 pL (5.0 mM) of either negative siRNAs or
p66Shc-specific siRNA molecules RNAi-A or RNAi-E. Following
microinjection, embryos were cultured to the 2–4 cell stage
(32 hpi) before being processed for whole-mount immunofluorescence for semi-quantitative comparative analysis of total Shc
protein (p46Shc, p52Shc and p66Shc isoforms) and activated
(serine 36 phosphorylated) p66Shc protein content by relative
fluorescent intensities (Figure 2; Supplemental Figure S3).
Embryos
injected
with
negative
control
siRNAs
(13.1860.746103 pixels) exhibited significantly (P,0.05) higher
levels of total Shc protein than non-injected controls
(10.6160.156103 pixels). While both anti-p66Shc siRNA molecules produced a significant (P,0.05) decrease in total Shc
protein, RNAi-E (2.2460.346103 pixels; 83.0% decrease vs.
negative siRNAs) generated a significantly greater reduction than
RNAi-A (4.3760.526103 pixels; 66.8% decrease vs. negative
siRNAs). In addition, no significant (P.0.05) difference in Serine
36 phosphoryated p66Shc was observed between non-injected
embryos (6.5460.496103 pixels) and embryos injected with
negative siRNA (7.2960.586103 pixels). Embryos injected with
RNAi-E (0.9960.396103 pixels) exhibited levels of phosphorylated-p66Shc protein significantly lower than control groups
(Supplemental Figure S3). These results demonstrated efficient
and specific knockdown of total and activated p66Shc protein
levels, respectively, in early bovine embryos.

PLOS ONE | www.plosone.org

p66Shc Knockdown Reduces Early Embryonic Failure
To determine the outcome of RNAi-mediated knockdown of
p66Shc on early bovine development, groups (n = 100/r, r = 3) of
zygotes were either non-injected, or injected with 10pL (5.0 mM)
of negative control siRNAs, RNAi-A, or RNAi-E molecules.
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Figure 3. RNAi-mediated knockdown of p66Shc reduces
embryo failure and increases blastocyst development. Groups
of embryos were either: non-injected, injected with negative control
siRNA molecules or injected with the p66Shc-specific siRNA molecules
RNAi-A or RNAi-E. The frequency distribution of embryo development
was assessed on the 8th day of in vitro culture. Different letters above
the histogram bars represent significant differences (P,0.05) in
developmental frequencies between groups. The proportion of 2–4
cell embryos was increased by the negative control siRNA while both
p66Shc specific siRNA molecules produced significant decreases in
embryo arrest. The distribution of 5–8 cell embryos was unaffected by
any treatment. The proportion of 9–16 cell embryos was significantly
decreased in both p66Shc-specific siRNA groups. Negative siRNA
injection significantly decreased the proportion of blastocyst stage
embryos. The proportion of both morula and blastocyst stage embryos
was increased by both of the anti-p66Shc siRNA molecules.
doi:10.1371/journal.pone.0086978.g003

Figure 2. Quantification of total Shc protein levels by semiquantitative immunofluorescence following RNAi-mediated
knockdown of p66Shc in early bovine embryos. Groups of 2–4
cell embryos were immunoassayed for total Shc protein levels by
relative immunofluorescent signal intensities. Embryo groups were
either non-injected controls; injected with negative control siRNA
molecules, or injected with the p66Shc-specific siRNA molecules RNAi-A
or RNAi-E. Significant differences (P,0.05) are noted by different letters
above the histogram bars. Embryos injected with the negative control
siRNA molecule displayed significantly higher levels of Shc protein than
non-injected controls. Embryos injected with either RNAi-A or RNAi-E
siRNAs exhibited a significant decrease in Shc protein levels. Embryos
injected with RNAi-E experienced a significantly greater decrease in Shc
protein levels than the RNAi-A injected embryos. Scale bar, 50 mM.
doi:10.1371/journal.pone.0086978.g002

Following microinjection, embryos were cultured until IVC day 8
(192 hpi) at which point they were assessed in terms of
developmental progress (Figure 3). For this experiment, embryos
that had failed to cleave were eliminated from the sample groups
after 32 hpi. It should be noted when interpreting these results that
a much higher proportion of embryos that underwent microinjection (20–25%) failed to cleave as compared to non-injected
controls (8–12%). Non-injected control embryos exhibited the
typical ‘‘inverted bell’’ distribution of embryo stages at 192 hpi.
Embryos injected with the negative siRNA experienced a
significantly (P,0.05) increased frequency of embryo failure at
the 2–4 cell and 9–16 cell stage compared to non-injected controls.
Additionally, the proportion of blastocysts (25.8160.23%) was
significantly (P,0.05) lower amongst negative siRNA injected
embryos than all other groups. Conversely, embryos injected with
either p66Shc-specific RNAi-A or RNAi-E siRNAs generated
remarkably similar developmental profiles, remaining statistically
similar within each developmental stage. Both RNAi-A and
RNAi-treated embryos experienced significantly (P,0.05) less
developmental failure at the 2–4 cell and 9–16 cell stages.
Additionally, the proportion of blastocyst-stage embryos (RNAiA = 36.060.58%; RNAi-E = 37.3560.50%) was significantly
(P,0.05) higher than even the non-injected control
(30.9761.16%) and negative siRNAs injected (25.8160.77%)
embryos. These results indicate that RNAi-mediated knockdown
of p66Shc significantly reduces the rate of developmental failure at
the 2–4 cell (permanent embryo arrest) and 9–16 cell (embryo
apoptosis) stages while increasing the frequency of blastocyst
development.

PLOS ONE | www.plosone.org

RNAi-mediated Knockdown of p66Shc Reduces
Intracellular ROS Levels
To assess the effect of RNA-mediated p66Shc knockdown on
embryo intracellular reactive oxygen species (ROS) content,
groups (n = 50/r, r = 3) of zygotes were either non-injected
(control), or injected with 10 pL (5.0 mM) of negative control
siRNAs, RNAi-A, or RNAi-E molecules. Following RNAi
microinjection embryos were cultured to the 2–4 cell stage
(32 hpi) before being subjected to 29, 79-di- chlorofluorescein
(DCF) staining for intracellular ROS quantification by comparative analysis of relative fluorescent intensities (Figure 4A,B). Both
control groups [non-injected embryos (25.7060.156103 pixels)
and negative control siRNAs injected embryos (25.9160.136103
pixels)] exhibited significantly (P,0.05) higher levels of intracellular ROS than embryos that had been injected with either RNAiA (25.3360.166103 pixels) or RNAi-E (25.2860.136103 pixels).
It should be noted that intracellular ROS levels were not
significantly (P.0.05) higher amongst negative siRNA injected
embryos as compared to non-injected controls. This data indicates
that RNAi-mediated knockdown of p66Shc is sufficient in
generating a significant decrease in embryo intracellular ROS
content at 32 hpi.

Reduced DNA Damage Following RNAi-mediated
Knockdown of p66Shc
To measure the effect of RNAi-mediated p66Shc knockdown
on ROS-associated DNA damage, groups (n = 50/r, r = 3) of
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Figure 4. Decreased intracellular ROS and associated DNA damage following RNAi-mediated knockdown of p66Shc in early bovine
embryos. Groups of 2–4 cell embryos were stained with 29,79-di- chlorofluorescein (DCF) and immunoassayed for phosphorylated c-H2A.X protein
to measure intracellular reactive oxygen species (ROS) content and DNA damage, respectively. Embryos groups were either non-injected controls,
injected with negative control siRNA molecules, or injected with the p66Shc-specific siRNA molecules RNAi-A or RNAi-E. (A) Representative
fluorescent images of DCF stained embryos. (B) A slight, non-significant increase in intracellular ROS was observed in negative siRNA-injected
embryos over non-injected controls. Embryos injected with p66Shc-specific siRNA molecules exhibited significantly (P,0.05) reduced ROS levels.
Different letters above the histogram bars represent significant differences (P,0.05) in intracellular ROS intensities. There were no significant
difference between RNAi-A and RNAi-E injected embryos observed. (C & D) Quantification of ROS-associated DNA damage following RNAi-mediated

PLOS ONE | www.plosone.org
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p66Shc knockdown. Groups of 2–4 cell embryos were stained for phosphorylated c-H2A.X protein for quantification by relative immunofluorescent
signal intensities. Embryos were: non-injected (controls), injected with negative control siRNA molecule, or injected with the p66Shc-specific siRNA
molecules RNAi-A or RNAi-E. (C) Representative fluorescent images of phospho-c-H2A.X stained embryos. (D) Negative siRNAinjected embryos
exhibited significantly higher levels of phosphorylated c-H2A.X protein than non-injected controls. Embryos injected with either RNAi-A or RNAi-E
molecules exhibited a significant decrease in phosphorylated c-H2A.X signal intensities compared to controls. Different letters above the histogram
bars represent significant differences (P,0.05) in mean phospho-c-H2A.X fluorescent intensities. Scale bar, 50 mM.
doi:10.1371/journal.pone.0086978.g004

protein (5.4760.306103 pixels). Among the embryo subgroups
treated with H2O2, a similar yet overall increase abundance of
p66Shc
protein
was
observed.
Both
non-injected
(31.5360.496103 pixels) and negative siRNA injected
(33.2460.676103 pixels) embryos exhibited extremely high levels
(P,0.05) of p66Shc protein (Figure 6). Again, those embryos
injected with RNAi-E before H2O2 treatment exhibited significantly (P,0.05) lower levels of total Shc protein (9.6160.506103
pixels) than control groups treated with H2O2 (Figure 6). The
results of these experiment suggest that RNAi-mediated knockdown of p66Shc confers protection against an H2O2-induced
increase in total Shc levels.

zygotes were either non-injected or injected with 10 pL (5.0 mM)
of negative control siRNAs, RNAi-A, or RNAi-E. Following
microinjection embryos were cultured to the 2–4 cell stage (32 hpi)
before being processed for whole mount immunofluorescence for
semi-quantitative comparative analysis of phosphorylated cH2A.X protein content by relative fluorescent intensities
(Figure 4C,D). Embryos injected with negative siRNAs exhibited
significantly (P,0.05) greater levels of phosphorylated c-H2A.X
fluorescent intensities (2.9360.176103 pixels) than non-injected
controls (2.4260.106103 pixels) or either p66Shc RNAi-injected
group. Embryos microinjected with anti-p66Shc siRNAs, exhibited a significant (P,0.05) decrease in phosphorylated c-H2A.X
protein staining with RNAi-E producing the greatest reduction
(0.9160.056103 pixels). This data supports the view that RNAimediated knockdown of p66Shc significantly reduces ROSassociated DNA damage in early bovine embryos.

p66Shc Knockdown Embryos Generate Lower
Intracellular ROS Levels
Groups (n = 100/r, r = 3) of zygotes were either non-injected or
injected with 10 pL (5.0 mM) of either negative control siRNAs or
p66Shc-specific siRNA RNAi-E. Following microinjection, embryos were cultured to the 2–4 cell stage (32 hpi) and subdivided
into two subgroups (n = 50) that were either untreated or treated
with 50 mM H2O2 for 1 hr. Following H2O2 treatment, embryos
were cultured an additional 6 h before being subjected to DCF
staining for intracellular ROS quantification by comparative
analysis of relative fluorescent intensities (Figure 7A,B). Noninjected (25.3760.136103 pixels) and negative siRNA-injected
(25.5160.166103 pixels) embryos exhibited significantly (P,0.05)
higher levels of intracellular ROS than embryos injected with
RNAi-E (24.8860.166103 pixels). The groups of embryos treated
with H2O2 exhibited a similar, yet overall increased pattern of
intracellular ROS levels. Non-injected (26.6760.196103 pixels)
and negative siRNA-injected (26.7960.216103 pixels) embryos
that were treated with H2O2 exhibited significantly (P,0.05)
higher levels of ROS than embryos injected with RNAi-E
(26.1060.116103 pixels). Intracellular ROS content follows a
similar correlative pattern as the p66Shc mRNA and Shc protein
abundance following the combined effects of p66Shc RNAi and
H2O2 treatment. The reduced intracellular ROS generation
following exogenous H2O2 treatment suggest that p66Shc
knockdown by RNAi diminishes the oxidative stress response in
early embryos.

Stress-induced Elevation in p66Shc Levels are Reduced in
Knockdown Embryos
To gauge the effect of oxidative stress on embryo p66Shc levels,
groups (n = 100/r, r = 3) of zygotes were either non-injected
(control) or injected with 10 pL (5.0 mM) of either negative control
siRNAs or with p66Shc-specific siRNA molecules (RNAi-E).
Following embryo microinjection and subsequent culture to the 2–
4 cell stage (32 hpi) the embryos were subdivided into two
subgroups (n = 50), which were either left untreated, or treated
with 50 mM hydrogen peroxide (H2O2) for 1 hr. All subgroups
were cultured a further 14 h (48 hpi) before being pooled and
processed for total RNA extraction for p66Shc mRNA quantification and whole mount immunofluorescence for semi-quantitative comparative analysis of p66Shc protein content by relative
fluorescent intensities (Figures 5 & 6). Histone H2A mRNA was
quantified in parallel during these experiments as a control of PCR
efficiency (Figure 5B). No significant differences (P.0.05) in H2A
mRNA were observed between treatment groups. Embryo
subgroups not treated with H2O2 exhibited the anticipated pattern
of p66Shc mRNA abundance with negative siRNA injected
embryos displaying significantly (P,0.05) greater levels of p66Shc
mRNA (3.6160.2061026 pg) than non-injected embryos
(2.8260.3061026 pg) while RNAi-E injected embryos showed
significantly (P,0.05) less (0.2460.1261026 pg). Among the
subgroup of embryos treated with H2O2 a similar yet elevated
pattern of p66Shc mRNA abundance was observed. Both noninjected (4.6260.3461026 pg) and negative siRNA injected
(4.8560.3561026 pg) embryos exhibited extremely high levels of
p66Shc mRNA. As was anticipated, those embryos injected with
RNAi-E prior to H2O2 treatments exhibited significantly (P,0.05)
lower quantities of p66Shc mRNA (1.6460.4661026 pg) than
H2O2 treated control groups.
Total Shc protein content (Figure 6) strongly resembled the
p66Shc mRNA data (above). Non-injected embryo subgroups
exhibited the anticipated pattern of total Shc protein abundance
with negative siRNA injected embryos exhibiting significantly
(P,0.05) greater levels of Shc protein (23.5960.576103 pixels)
than non-injected embryos (16.7361.236103 pixels), while those
injected with RNAi-E exhibited significantly (P,0.05) less Shc
PLOS ONE | www.plosone.org

Reduced DNA Damage Following p66Shc Knockdown
and H2O2 Treatment
Since the stress response was found reduced in p66Shc
knockdown embryos we wanted to examine their degree of
DNA damage. Groups (n = 100/r, r = 3) of zygotes were noninjected or injected with 10 pL (5.0 mM) of either negative control
siRNAs or p66Shc-specific RNAi-E. Following microinjection,
embryos were cultured to the 2–4 cell stage (32 hpi) and
subdivided into two subgroups (n = 50) that were either untreated,
or treated with 50 mM H2O2 for 1 hr. All subgroups were cultured
a further 14 h (48 hpi) before being processed for whole mount
immunofluorescence for semi-quantitative comparative analysis of
the damage marker phosphorylated c-H2A.X using relative
fluorescent intensities (Figure 7C,D). A bimodal pattern of
phospho-c-H2A.X protein abundance was observed within
6
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Figure 5. Knockdown of p66Shc ameliorates H2O2-induced increase in p66Shc mRNA levels in early bovine embryos. Following a
combination of siRNA molecule microinjection and hydrogen peroxide (H2O2; 50 mM) treatments, total RNA was extracted from pooled groups of 5–
8 cell embryos for p66Shc mRNA quantification. (A) Non-H2O2 treated embryos injected with negative siRNA exhibited significantly higher levels of
p66Shc mRNA than non-injected controls. Embryos injected with the RNAi-E siRNA molecule exhibited significantly less p66Shc mRNA. H2O2 treated
embryos injected with RNAi-E exhibited significantly lower levels of p66Shc mRNA. However, RNAi-E injected embryos treated with H2O2 exhibited
significantly greater amounts of p66Shc mRNA than RNAi-E injected embryos that were not exposed to H2O2. (B) Histone H2A mRNA was quantified
in parallel as internal controls for PCR efficiency. No significant differences in H2A mRNA were noted between treatment groups. Different letters
above the histogram bars represent significant differences (P,0.05) in p66Shc mRNA abundance between groups.
doi:10.1371/journal.pone.0086978.g005

direct 50 mM H2O2 treatment. It should be noted that this
protective effect, although statistically significant, is only partial
since embryos injected with RNAi-E ahead of H2O2 treatment still
exhibited significantly (P,0.05) greater amounts of ROS-associated DNA damage than similarly-injected, H2O2 untreated
embryos.

untreated and H2O2-treated embryo groups. Among the subgroup
not treated with H2O2, embryos injected with negative siRNA
(4.9360.486103 pixels) exhibited significantly (P,0.05) greater
levels of phosphorylated c-H2A.X protein than non-injected
controls (3.7860.426103 pixels). Embryos injected with RNAi-E
(2.4860.246103 pixels) exhibited significantly (P,0.05) less
phosphorylated c-H2A.X protein than either control group.
Among the subgroups treated with H2O2, a slightly different
and overall increased pattern of phospho-c-H2A.X protein
abundance was observed. Both non-injected (6.8260.426103
pixels) and negative siRNA injected (7.1160.676103 pixels)
groups exhibited particularly high, statistically similar levels of
phosphorylated c-H2A.X protein content. The group injected
with the p66Shc siRNA molecule RNAi-E (5.5260.216103 pixels)
before H2O2 treatment exhibited significantly (P,0.05) less
phosphorylated c-H2A.X protein content than H2O2-treated
controls. This data confirms that p66Shc knockdown by RNAi
confers protection against ROS-induced DNA damage, even after
PLOS ONE | www.plosone.org

p66Shc Knockdown Embryos Exhibit Reduced
Frequencies of Stress-induced Permanent Embryo Arrest
and Apoptosis
In order to developmentally evaluate the efficacy of this
protective effect of p66Shc knockdown against H2O2-induced
DNA damage, groups (n = 100/r, r = 3) of zygotes were either
non-injected (control) or microinjected with 10 pL (5.0 mM) of
either negative control siRNAs or of p66Shc RNAi molecule
RNAi-E. Following microinjection, embryos were cultured to the
2–4 cell stage (32 hpi) before being subjected to a 1 hr treatment
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and propidium iodide (PI) staining (Figure 8A–E). An embryo was
considered apoptotic only if it displayed both TUNEL-positive
staining and nuclear condensation/fragmentation under PI
staining in the same blastomere. Embryos injected with negative
siRNAs (88.165.5%) exhibited a significantly (P,0.05) higher
incidence of apoptosis than non-injected embryos (74.862.8%).
Importantly, embryos injected with RNAi-E (54.565.8%) exhibited a significantly (P,0.05) lower incidence of apoptosis than both
control groups. This data confirms that the protective effect
conferred by p66Shc RNAi against 2–4 cell embryo arrest is also
present at the 9–16 cell stage providing protection against H2O2induced apoptosis.
RNAi-mediated knockdown of p66Shc in early embryos has
demonstrated a protective effect against two forms of stressinduced developmental failure: permanent embryo arrest and
embryo apoptosis. As a follow-up to these experiments, the ability
of p66Shc knockdown to promote stress resistant development was
assessed. Groups (n = 50/r, r = 3) of zygotes were non-injected or
microinjected with 10 pL (5.0 mM) of either negative siRNAs or
p66Shc RNAi molecules (RNAi-E). Following microinjection,
each group of zygote-stage embryos was immediately subjected to
a 1 hr treatment of 50 mM H2O2. Embryos were cultured for 8
days (192 hpi) at which point the frequency of successful blastocyst
formation was visually assessed (Figure 8F). Significantly fewer
(P,0.05) embryos injected with negative control siRNAs successfully developed into blastocysts after H2O2 treatment
(8.9762.41%)
than
non-injected
control
embryos
(18.1861.94%). A significantly greater (P,0.05) proportion of
embryos that were injected with the p66Shc-specific siRNA
molecule RNAi-E (15.7962.66%) successfully developed into
blastocysts compared to negative siRNA-injected embryos. However, RNAi-E injected embryos did not successfully develop into
blastocysts significantly (P.0.05) more often than non-injected
control embryos. Taking into consideration the negative effects of
the microinjection process itself on embryo development, this data
confirms that p66Shc RNAi does improve the frequency of
successful blastocyst development following H2O2 treatment of
zygotes.

Figure 6. Knockdown of p66Shc ameliorates H2O2-induced
increase in p66Shc protein levels in early bovine embryos.
Following a combination of p66Shc siRNA molecule microinjection and
H2O2 (50 mM) treatments, groups of 5–8 cell embryos were immunoassayed for total Shc protein (p46, p52, p66 isoforms) for quantification
by relative immunofluorescent signal intensities. Embryos were either:
non-injected controls, injected with negative control siRNAs, or injected
with p66Shc specific siRNA molecules RNAi-E. (A) Representative images
of Shc immunolocalized embryos. (B) Relative Shc fluorescent intensities
in Non-H2O2 treated embryos injected with siRNAs were significantly
higher than non-injected controls. Embryos injected with the RNAi-E
siRNA molecules displayed significantly reduced Shc immunofluorescent levels. H2O2 treated embryos injected with RNAi-E siRNA molecule
exhibited significantly lower levels of Shc, however, RNAi-E injected
embryos treated with H2O2 exhibited significantly greater amounts of
Shc immunofluorescence than similarly injected embryos that were not
exposed to H2O2. Different letters above the histogram bars represent
significant differences (P,0.05) in mean fluorescent intensities. Scale
bar, 50 mM.
doi:10.1371/journal.pone.0086978.g006

Nuclear Exclusion of FOXO3a is Reduced by p66Shc
Knockdown

of either 100 mM or 50 mM H2O2. Embryos were cultured an
additional 40 h (to 72 hpi) at which point the frequency of
permanent 2–4 cell arrest was assessed (Table 1). Embryos treated
with 100 mM H2O2 succumbed to permanent embryo arrest
regardless of injection treatment. However, embryos treated with
50 mM H2O2 exhibited a more complex pattern of embryo arrest.
Those injected with negative siRNA before 50 mM H2O2
treatment exhibited a significantly (P,0.05) higher rate of 2–4
cell arrest than non-injected controls. Most importantly, embryos
injected with p66Shc siRNA molecule RNAi-E before the 50 mM
H2O2 treatment exhibited a significantly reduced rate of 2–4 cell
arrest compared to both control groups. This data indicates that
although certain threshold dose levels of exogenous H2O2 may be
insurmountable, the protective effect of p66Shc RNAi is sufficient
to significantly reduce the incidence of stress-induced permanent
2–4 cell embryo arrest.
In order to assess the protective effect of p66Shc RNAi against
H2O2-induced embryo apoptosis, groups (n = 100/r, r = 3) of
zygotes were either non-injected or injected with 10 pL (5.0 mM)
of either negative control siRNAs or of p66Shc siRNA molecules
(RNAi-E). Following microinjection, embryos were cultured to the
9–16 cell stage (72 hpi) and subjected to a 1 hr treatment of
50 mM H2O2. Embryos were cultured an additional 6 h before
their apoptotic status was evaluated by a combination of TUNEL
PLOS ONE | www.plosone.org

FOXO3a, a member of the forkhead family of transcription
factors, regulates several important antioxidant enzymes. Ser36phosphorylated p66Shc, mediated by Akt, excludes FOXO3a
from the nucleus impairing antioxidant expression [37]. Groups
(n = 50/r, r = 3) of embryos were cultured under 5% O2 (controls),
20% O2, divided by the time of first cleavage division (Early
,28 hpi; Late .28 hpi), or subjected to a 1 hr treatment with
50 mM H2O2 at the 2–4 cell stage (32 hpi). Embryos were cultured
to 38 hpi and processed for whole mount immunofluorescence for
the localization of FOXO3a protein by confocal microscopy.
Embryos were co-stained with DAPI and FOXO3a in order to
identify both nuclear boundaries as well as FOXO3a localization.
The FOXO3a distribution pattern of each embryo was evaluated
individually (Supplementary Figure S4). Embryos exhibiting the
‘‘nuclear exclusion’’ pattern of FOXO3a staining were enumerated (Supplementary Table S3). Nuclear exclusion of FOXO3a
was observed to be not significantly different and at a low
incidence (4–5%) among all treatment groups with the exception
of embryos treated with 50 mM H2O2, which exhibited significantly (P,0.05) elevated levels (,55%) of nuclear exclusion.
In addition, groups (n = 50/r, r = 3) of zygote-stage embryos
were either non-injected (controls), or injected with 10 pL
(5.0 mM) of either negative siRNA molecules or p66Shc-specific
8
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Figure 7. RNAi-mediated knockdown of p66Shc reduces H2O2-induced ROS accumulation and DNA damage in early bovine
embryos. Following a combination of microinjection and H2O2 (50 mM) treatments, groups of 5–8 cell bovine embryos were stained with 29,79-dichlorofluorescein (DCF) and immunoassayed for phosphorylated c-H2A.X protein to measure intracellular ROS content and DNA damage,
respectively. Embryos were either: non-injected controls, injected with negative control siRNA molecules, or injected with RNAi-E molecules that
specifically target p66Shc. (A) Representative fluorescent images of DCF stained embryos. (B) Non-H2O2 treated embryos injected with RNAi-E
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exhibited significantly lower levels of intracellular ROS than negative control siRNA-injected and non-injected control embryos. H2O2 treated embryos
injected with RNAi-E exhibited significantly lower ROS levels than negative control siRNA-injected and non-injected controls. However, RNAi-E
injected embryos exposed to H2O2 exhibited significantly greater amounts of intracellular ROS than any groups not exposed to H2O2. (C)
Representative images of phosphorylated c-H2A.X immunolocalized bovine embryos. (D) Following a combination of siRNA molecule microinjection
and H2O2 treatments, groups of 5–8 cell embryos were stained for phosphorylated c-H2A.X protein for quantification by relative immunofluorescent
signal intensities. Non-H2O2 treated embryos injected with negative control siRNAs exhibited significantly higher levels of phosphorylated c-H2A.X
protein than non-injected controls. Embryos injected with the RNAi-E siRNA exhibited significantly less phosphorylated c-H2A.X protein than controls.
H2O2 treatment of RNAi-E-injected embryos resulted in significantly lower levels of phosphorylated c-H2A.X protein than either control groups.
However, RNAi-E injected embryos treated with H2O2 exhibited significantly greater amounts of c-H2A.X protein than any groups not exposed to
H2O2. Different letters above the histogram bars represent significant differences (P,0.05) in relative fluorescent intensity between groups. Scale bar,
50 mM.
doi:10.1371/journal.pone.0086978.g007

(3.2960.296103 pixels) or negative control siRNA-injected
(3.3760.596103 pixels) embryos (Figure 9A,B).
To examine the impact of MnSOD upregulation, 2–4 cell
embryos (38 hpi; n = 50/r, r = 3) were subjected to live-cell
MitoSOXTM staining for comparative superoxide quantification
between treatment groups (Figure 9C,D). Embryos injected with
RNAi-E (11.9160.196103 pixels) exhibited significantly lower
(P,0.05) superoxide levels than non-injected (12.7060.126103
pixels) and negative control siRNA injected embryos
(12.7860.156103 pixels). These observations further support the
model that RNAi-mediated knockdown of p66Shc confers a
protective effect over ROS-associated DNA damage and embryonic failure by positively influencing the expression and activity of
at least one key antioxidant enzyme.

siRNAs (RNAi-E). Following microinjection, embryos were
cultured to the 2–4 cell stage (38 hpi) before being processed for
whole mount immunofluorescence for localization of FOXO3a
protein under immunofluorescent confocal microscopy. Embryos
co-stained with DAPI and FOXO3a were individually assessed
(Supplementary Figure S4). Embryos exhibiting ‘‘nuclear exclusion’’ of FOXO3a immunolocalization were counted (Table 2). A
significantly greater (P,0.05) proportion of embryos injected with
negative control siRNAs exhibited nuclear exclusion of FOXO3a
compared to non-injected controls. Embryos injected with RNAiE exhibited significantly less (P,0.05) FOXO3a nuclear localization than embryos injected with negative siRNA although nuclear
incidence remained significantly above those of non-injected
controls. This data indicates FOXO3a translocation can be
significantly affected by RNAi-mediated knockdown of p66Shc.

Discussion

Elevated MnSOD Activity Following RNAi-mediated
Knockdown of p66Shc

The aim of this study was to elucidate the functional role(s) of
p66Shc throughout early embryo development. We have previously determined that elevated p66Shc mRNA and protein
abundance in early embryos are associated with reduced
developmental potential [22,29]. We have also shown that the
early embryo’s response to reactive oxygen species (ROS) is
developmental regulated [27] and that activated p66Shc is linked
to increased intracellular ROS levels, reduced antioxidant
expression and to permanent embryo arrest [22,28,29]. Previous
microinjections of short hairpin (sh)RNAi molecules targeting
p66Shc in immature bovine oocytes successfully knockdown
p66Shc and alleviated the 2–4 cell block observed after
fertilization, but also resulted in reduced blastocyst development
suggesting a role for p66Shc beyond early cleavage arrest [30].
Herein, we mechanistically demonstrate for the first time that
RNAi-mediated knockdown of p66Shc at the zygote stage confers
oxidative stress resistance throughout early bovine embryo
development. P66Shc knockdown embryos are more resistant to
oxidant treatment due to increased levels of MnSOD and a
reduction in intracellular ROS and DNA damage content that
diminishes the frequencies of both permanent embryo arrest and
apoptosis resulting in improved blastocyst development in vitro.
According to a series of criteria [43], two non-overlapping
siRNA sequences (RNA-A, RNA-E) were designed to specifically
target the unique CH2 domain of bovine p66Shc. These siRNAs
were different than the previous p66Shc shRNA sequence utilized
in our previous study [30]. The use of multiple target sequences of
the same RNA molecule is an effective means of verifying a
genuine loss-of-function effect [44]. While both siRNA molecules
induced a significant decrease in p66Shc mRNA and protein,
RNAi-E was the more effective of the two. The accessibility to the
target sequence may be greater for RNA-E molecules than for
RNAi-A siRNAs. A difference in the internal stability of the two
siRNA molecules could manifest as different rates of strand
selection and entry into the RNA-induced silencing complex

Groups (n = 50/r, r = 3) of zygotes were either non-injected
(controls), or injected with 10 pL (5.0 mM) of either negative
control siRNAs or p66Shc-specific RNAi-E molecules. Following
microinjection, embryos were cultured to the 5–8 cell stage
(48 hpi) before being pooled and harvested for total RNA for the
Real Time PCR quantification of catalase and MnSOD mRNA
(Supplemental Figure S5), whole mount immunofluorescence for
semi-quantitative comparative analysis of catalase and MnSOD
protein content by relative fluorescent intensities (Figure 9A,B). No
significant differences (P.0.05) in catalase mRNA content were
observed between any of the treatment groups, while p66Shc
knockdown induced significantly higher (P,0.05) levels of
MnSOD mRNA (5.9560.1361025 pg) than control groups
(non-injected embryos: 5.5160.1461025 pg; negative siRNA
injected: 5.5660.1061025 pg). No significant (P.0.05) differences in H2A mRNA were observed between any treatment groups.
Likewise, no significant (P.0.05) differences in catalase protein
content were observed between any of the treatment groups
(Supplementary Figure S6). However, consistent with MnSOD
mRNA data, embryos injected with the p66Shc siRNA molecule
RNAi-E (5.8060.596103 pixels) exhibited significantly higher
(P,0.05) levels of MnSOD protein than either non-injected
Table 1. The effect of p66Shc knockdown on H2O2-induced
permanent embryo arrest*.

Groups
100 mM H2O2
50 mM

H2O2¥

Untreated
¥

98.761.3%

a

40.962.9%

a

Negative siRNA
10060%

a

69.265.5%

RNAi-E
10060%a

b

32.761.8%c

¥
n = 100/replicate, 3 replicates.
*Superscript letters denote significant differences (P,0.05) within groups.
doi:10.1371/journal.pone.0086978.t001
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Figure 8. Knockdown of p66Shc ameliorates H2O2-induced apoptosis and developmental arrest of early bovine embryos. Groups of
zygotes (n = 50/r, r = 3) were either: non-injected controls, injected with negative control siRNAs, or injected with p66Shc siRNA molecules (RNAi-E). At
the 9–16 cell stage, all groups were subjected to 50 mM H2O2 treatment for 1 hr. After an overnight incubation, embryos were fixed and stained with
a mixture of TUNEL labeling stain (green) and propidium iodide (red) to assess their apoptotic status. (A) Representative negative control embryo
stained in the absence of active TUNEL enzyme. (B) Representative positive control embryo subjected to DNase treatment before TUNEL stain. (C)
Representative apoptotic 9–16 cell embryo displaying TUNEL positive stain in conjunction with nuclear condensation and fragmentation. (D)
Representative non-apoptotic 9–16 cell embryo displaying TUNEL negative staining in conjunction with intact nuclear staining. (E) Summary of the
incidence of apoptosis following RNAi microinjection and H2O2 treatments. While embryos injected with negative siRNA molecules exhibited a
greater proportion of apoptosis, embryos injected with RNAi-E exhibited a significantly reduced incidence of apoptosis. (F) The effect of p66Shc
knockdown on the frequency of blastocyst formation following H2O2 treatment. Groups of embryos (non-injected, negative control siRNA- injected,
or RNAi-E injected, were subjected to a 1 hr treatment of 50 mM H2O2 at the 2–4 cell stage after which they were allowed to develop until the 8th day
of culture (192 hpi) at which point the frequency of blastocyst development was assessed. A significantly greater proportion of embryos injected with
the p66Shc-specific siRNA molecules (RNAi-E) successfully developed into blastocysts compared to those injected with a negative control siRNA. The
proportion of blastocysts amongst the RNAi-E group was comparable to that of the non-injected control group. Different letters above the histogram
bars represent significant differences (p,0.05). Scale bar, 50 mM.
doi:10.1371/journal.pone.0086978.g008

A greater proportion of p66Shc knockdown embryos significantly reached the morula and blastocyst stages than control
groups following eight days of embryo culture. As the microinjection process itself significantly increased the incidence of embryos
that failed to cleave, only those embryos that had undergone at
least one successful cleavage division were evaluated. Previous
reports have observed a similar decrease in cleavage and blastocyst
frequencies after microinjection of bovine oocytes [30] and zygotes
[48]. While this strategy suppresses the negative consequences of
microinjection, it emphasizes the extent of any RNAi-mediated
knockdown effects on development. As a result, we observed a
significant decrease in the incidence of embryonic failure at the 2–
4 cell and 9–16 cell stages with a concomitant increase in the
number of morulae and blasocysts at day eight of embryo culture.
A similar reduction in early cleavage arrest was observed in our
previous study in which p66Shc was knockdown by shRNA
injection of immature bovine oocytes, however blastocyst
frequencies were significantly reduced [30]. This decrease in
blastocyst production was possibly due to the knockdown of
additional Shc isoforms (p52 and p46), which are involved in
mitogenic signalling [31] and have been found to be necessary for
proper embryo development [49], or more likely due to the reexppresion of p66Shc at later cleavage stages due to shRNA
dilution. In this current study, the knockdown of p66Shc mRNA
was greatest amongst 2–4 cell embryos, yet remained significantly

(RISC) leading to differential knockdown efficiencies [45,46]. A
significant increase in p66Shc mRNA and protein was observed in
embryos injected with negative control siRNAs compared to noninjected embryos. The microinjection process, which involves
prolonged exposure to ambient temperature and oxygen tensions,
as well as disruption of the cell membrane and components of the
cytoskeleton, is a significant stress upon the early bovine embryo
[47]. This upregulation may mask the true knockdown effect of
p66Shc siRNA molecules, which may prove more effective if
introduced in a less traumatic manner. Attempts introducing
siRNAs into bovine zygotes using lipofectamine were futile.
Table 2. The incidence of FOXO3a nuclear exclusion
following RNAi-mediated knockdown of p66Shc.
Treatment¥

% Nuclei FOXO3a Excluded*

Non-Injected

5.460.9a

Negative control siRNAs

15.162.4b

p66Shc siRNAs (RNAi-E)

10.261.9c

N
n = 50/replicate, 3 replicates;
*Significant differences (P,0.05) are denoted by superscript letters.
doi:10.1371/journal.pone.0086978.t002
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Figure 9. RNAi-mediated knockdown of p66Shc increases MnSOD levels and reduces superoxide production in early bovine
embryos. Bovine zygotes were either non-injected (controls), injected with negative control siRNA molecules, or injected with p66Shc-specific
siRNAs (RNAi-E). Groups of embryos were either stained for MitoSOXTM detection of superoxide levels or immunostained for MnSOD protein content
for quantification by relative fluorescent signal intensities. (A) Representative confocal images of 5–8 cell bovine embryos immunostained for MnSOD
protein. (B) Embryos injected with p66Shc siRNA molecule RNAi-E exhibited significantly higher levels of MnSOD protein than control groups. (C)
Representative confocal images of 2–4 cell bovine embryos were subjected to MitoSOXTM staining for superoxide quantification by relative
fluorescent signal intensity. (D) Embryos injected with p66Shc RNAi molecules exhibited significantly lower levels of superoxide content than control
groups. Different letters above the histogram bars represent significant differences (P,0.05) in mean fluorescent intensities. Scale bar, 50 mM.
doi:10.1371/journal.pone.0086978.g009

different at the 9–16 cell stage. In both studies [30], p66Shc
mRNA levels were virtually identical at the blastocyst stage in
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p66Shc knockdown embryos compared to embryos injected with
negative control RNAi molecules suggesting an optimal low
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lational regulation will further delineate the molecular control and
function of p66Shc expression during early embryo development.
P66Shc has been directly linked to ROS-induced apoptosis in
cultured somatic cells by targeted mutation of p66Shc that
rendered cells insensitive to p53-mediated apoptosis [36,41,59].
Oxidative stress promotes mitochondria translocation of p66Shc
where it mediates H2O2/ROS production through its interactions
and electron transfer with cytochrome c [38], either through
activated PKC-b, which triggers Ser-36 phosphorylation of
p66Shc [60–62] or through disulfide bond formation [63]. Thus,
activated p66Shc is necessary for the stress-activated, p53mediated release of cytochrome c from the mitochondrial
membrane that triggers apoptosis [36,41,64]. Our results clearly
demonstrate that activated p66Shc generates intracellular ROS
triggering oxidative stress-mediated permanent cell cycle arrest
and apoptosis in early bovine embryos. Preliminary data suggest
that telomere uncapping is behind this DNA damage response
(Betts and Madan, unpublished results). Interestingly, the decrease
in apoptosis induced by p66Shc knockdown was substantially
greater than the reduction in permanent 2–4 cell embryo arrest,
possibly suggesting differential regulation for p66Shc functions at
different stages of early development. Although Ser-36 phosphorylation of p66Shc has been widely implicated in its mitochondrial
ROS regulatory function [36,65], the forkhead transciption factor
FOXO3a, which induces expression of key antioxidant enzymes
such as MnSOD and catalase [66], is repressed by activated
p66Shc through Akt-mediated phosphorylation, which results in
FOXO3a exclusion from the nucleus [37,67]. FOXO3a activity as
well as catalase and MnSOD expression, has been found to be
increased in p66Shc2/2 cells [37,39,42,68]. We found that
p66Shc knockdown significantly diminished the stress-induced
nuclear exclusion of FOXO3a, increasing MnSOD levels and
reducing superoxide generation in 5–8 cell embryos. Conversely,
catalase/MnSOD mRNA and protein levels, when measured at
the 2–4 cell stage, were virtually unaffected by stress treatments
[29] suggesting that these antioxidants are not yet subject to
transcriptional control by FOXO at this early cleavage stage. This
discrepancy may account for the differential magnitude of early
and late cleavage stage p66Shc knockdown embryos in their
response to oxidative stress and developmental potential. A more
indepth examination of the p53-p66shc-MnSOD network [55,69]
and pharmacological treatment of early embryos with inhibitors of
p66Shc activation (e.g. PKC-b inhibitor hispidin) and its
mitochondrial translocation (e.g. Src tyrosine kinase inhibitor
PP2) will help delineate these varying functions during preimplantation development.
The ablation of p66Shc has been associated with a wide array of
health benefits [39,64,70]. At the cellular level, these effects
include an increased tolerance to oxidative stress-induced apoptosis [36], decreased generation of intracellular ROS [52], and
increased antioxidant expression [67]. Collectively, these effects
manifest at the organismal level in a variety of advantages
including resistance to atherosclerosis [40], resistance to injury
following ischemic reperfusion [71], and a significantly increased
lifespan [36]. Our study has uniquely demonstrated that RNAimediated knockdown of p66Shc improves early embryo development by providing oxidative-stress resistance against permanent
embryo arrest and apoptosis by diminishing intracellular ROS
generation and increasing the antioxidant capabilities of early
embryos. These mechanistic results indicate that the many benefits
of p66Shc reduction previously cited within the literature also
extend to improving the developmental competence of in vitro
produced mammalian embryos. Future systems biology approaches focussed on redox signaling and metabolic networks will greatly

p66Shc expression level for developmental competence. While we
didn’t evaluate p66Shc levels at the 9–16 cell stage in the previous
study we speculate that an earlier introduction of p66Shc RNAi
molecules in immature oocytes, although effective in knocking
down maternally-derived p66Shc transcripts and alleviating
embryo arrest, were diluted out and ineffective of curtailing
p66Shc-mediated apoptosis at later cleavage divisions. Alternatively, the negative impact of microinjecting immature oocytes
may be more severe than the microinjection of zygotes because of
the potential loss of surrounding cumulus cells [50,51] or that
known effects of p66Shc deficiency on altered metabolism [52]
and/or glucose uptake [35] were detrimental for further development when p66Shc was knockdown earlier. Although there was a
significantly greater degree of p66Shc knockdown by RNAi-E
siRNAs compared to RNAi-A molecules, interestingly, their effects
on embryo development were very similar. For example, both
p66Shc-specific RNAi-A and RNAi-E molecules induced a similar
significant reduction in intracellular ROS levels and DNA damage
that was not different between the two siRNAs. These similar
effects may indicate that the RISC complexes present with the
embryo have become saturated with siRNAs [53] or that p66Shc
abundance, below a certain threshold, produces a limited amount
of benefit on development that is not increased by further
knockdown. A titration series of a single p66Shc siRNA molecule
assessing developmental outcomes at different time points could
establish the limits of such a threshold and any altered affects on
embryo metabolism.
To further establish this relationship between improved
developmental outcomes with reduced intracellular ROS levels
and diminished DNA damage, RNAi-medicated knockdown of
p66Shc was combined with moderate H2O2 treatments to
determine whether p66Shc knockdown could confer stress
resistance against exogenous ROS exposure. In our hands,
p66Shc knockdown ameliorated ROS-induced p66Shc upregulation and activation reducing intracellular ROS generation and
subsequent DNA damage in early embryos. These novel results in
early embryos are analogous to previously published data on
p66Shc deficient somatic cells that showed a widespread stressresistent protective effect by reducing oxidative stress-induced
cellular damage and apoptosis that prolonged lifespan in knockout
mice [30,36,40–42]. Our initial H2O2 dose level of 100 mM was
found to be excessive with virtually all embryos from each
treatment groups succumbing to developmental failure. However,
a second, lower dose level of 50 mM proved to be more amenable
to improvement by p66Shc knockdown. This data confirms that
while certain threshold levels of exogenous ROS treatment may be
insurmountable, p66Shc knockdown is indeed able to confer
protection against ROS-induced 2–4 cell permanent embryo
arrest and apoptosis that rescues development to the blastocyst
stage. As we have shown before [29], oxidant/stress treatment of
embryos induces a massive upregulation of both p66Shc mRNA
and protein levels. P66Shc expression and protein stability are
highly responsive to intracellular ROS levels [54,55] and are due,
in part, to a ROS-mediated block in p66Shc ubiquitination and
degradation throught Ser-54 and Thr-386 phosphorylation of
p66Shc in a p38-dependent manner [56]. Enhanced stability of
p53 mRNA transcripts has been induced by oxidative stress
through a TIP 30-mediated process that triggers apoptosis [57].
Low levels of transcription has been observed before the major
activation of genome transcription in early embryos [58], making
early transcriptional/post-trancriptional regulation of p66Shc a
possibility as well. Future studies thoroughly examining p66Shc’s
transcriptional, post-transcriptional, translational and post-trans-
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Potential siRNA molecules were additionally screened based on
criteria established for rational siRNA design [43]. Two nonoverlapping siRNA molecules (Supplemental Table S4), which
best met the design criteria were synthesized (Life TechnologiesTM, USA) and utilized on zygote-stage bovine embryos via
microinjection. All p66Shc RNAi experiments were controlled
with groups of non-injected embryos as well as embryos injected
with a commercially available (Life Technologies, USA) medium
G/C content negative control siRNAs. These non-injected and
negative control siRNA-injected embryo groups were subjected to
the same culture conditions and treatments as the p66Shc-specific
siRNA-injected embryo groups (see below). The efficacy of the two
p66Shc-specific siRNA molecules (RNAi-A and RNAi-E) were
compared in terms of their respective abilities to knock-down
p66Shc mRNA and protein. A titration series (0, 0.005 mM,
0.05 mM, 0.5 mM, and 5.0 mM) of the siRNA molecule determined to be most effective (RNAi-E) was injected into groups
(n = 50/r, r = 3) of embryos which were analyzed for p66Shc
mRNA content at 32 hpi. The longevity of the p66Shc knockdown effect over time was evaluated by observing the p66Shc
mRNA content of RNAi-E injected groups (n = 50/r, r = 3)
embryos at the 2–4 cell, 9–16 cell and blastocyst stages.
For RNAi-mediated knockdown experiments, siRNAs were
introduced into zygote stage embryos via microinjection using a
LeicaH DMIRE2 inverted microscope equipped with a FemtoJetTM Injection System (Eppendorf International, USA). Holding
pipettes were custom forged from Borosilicate capillaries (Sutter
Instrument Company, USA) of an outer diameter of 1.0 mm,
inner diameter of 0.78 mm using a Flaming/Brown Micropipette
Puller (Sutter Instrument Company, USA) and a MF-900
Microforge (Narashige Group, Japan). Femtotip II (Eppendorf
International, USA) injection pipettes of an outer 1063 diameter of
1.0 mM, inner diameter 0.5 mM, back-loaded with 1.5 mL of
siRNA solution using MicroloaderH pipette tips (Eppendorf
International, USA) were used as injection pipettes. Both injection
and holding pipettes were controlled during microinjection using
TransferMan NK2 micro-manipulators (Eppendorf International,
USA), the pressure of the holding pipette being controlled via
CellTramH vario manual injector (Eppendorf International, USA).
Final injection volume was calculated using the following equation
based on the manufacture’s instructions of the PLI-100 PicoInjector (Harvard Apparatus Inc. USA): Volume (nL) = 0.179526
(tip inner diameter in mm)36 (Pressure in psi) 6 (Time in sec).
Presumptive zygotes were collected at 8 hpi, vortexed for 3 min to
remove excess sperm and cumulus cells, washed twice in prewarmed Sperm TALP and transferred into 40 mL oil-immersed
drops of Sperm-TALP in groups of 50. Embryos awaiting
microinjection were maintained in a humidified incubator at
38.5uC with 90% N2, 5% O2, 5% CO2. Zygotes were divided into
three groups (n $100): untreated embryos, embryos injected with
a negative control siRNA molecule, and embryos injected with one
of the p66Shc-specific siRNA molecules. A constant pressure of
15 hPA was present to prevent the backflow of medium into the
injection pipette. An injection pressure of 75 hPA for 0.1 s was
calculated to inject , 10 pL of solution into each embryo per
injection. Following microinjection, embryos were immediately
transferred into SOF media and cultured as previously described
[30]. Injection volume was optimized by treating groups (n = 50,
r = 3) of embryos with a titration (10 pL, 50 pL, 75 pL) of
injection volumes (of H2O) and assessing the rate of successful
cleavage at 32 hpi. The efficiency of microinjection using the
established optimal volume was evaluated by injecting groups
(n = 75/r, r = 3) of embryos with a FITC-conjugated oligonucle-

enhance our understanding of the molecular and signaling
processes governing preimplantation embryo development [72].
This new holistic information will enhance our ability to improve
embryo culture conditions, to select the most competent embryos
to transfer [73] and to minimize any detrimental effects of artificial
microenvironments to maximize healthy postnatal development of
in vitro produced livestock and individuals produced using assisted
reproductive technologies [74].

Materials and Methods
In vitro Embryo Production
In vitro bovine embryo production was carried out as previously
described [29]. Briefly, ovaries were freshly collected from a local
abattoir (Better Beef Ltd, Guelph, Ont., Canada) into a prewarmed (38.5uC) 0.9% saline solution. Upon laboratory arrival the
ovaries were placed into sealed containers with fresh saline
solution and maintained at 37.8uC in a humidified incubator until
follicular aspiration (,1–2 hr later). A vacuum pump (PipetAid
LR68701) attached to an 18-gauge needle was used to aspirate
cumulus-oocyte complexes (COCs) from 2–6 mm diameter
follicles. COCs were collected into HEPES-buffered Ham’s F10
(Sigma-Aldrich Canada, Canada) and separated from follicular
fluid by sedimentation (,15 min.) COCs of appropriate morphology (spheroid, uniform opacity) were sorted into TCM-199
media (Sigma-Aldrich Canada, Canada) supplemented with 2%
bovine serum (Cansera International, Canada), 0.2 mol/L sodium
pyruvate (Sigma-Aldrich Canada, Canada), 0.2 mol/L L-glutamine (Sigma-Aldrich Canada, Canada), and 0.6% penicillin/
streptomycin (Invitrogen, Canada). The final wash of TCM-199
was supplemented with 0.1 mg/ml of FSH, 1 mg/ml of LH and
1 mg/ml of estradiol (NIH, USA). COCs were matured in 80 ml
drops (20 COCs/drop) of TCM-199 with hormone supplement
under silicon oil (Paisley Products, Canada) for 22 hr at 38.5uC in
a humidified 5% CO2 atmosphere. Matured oocytes were washed
twice in HEPES-buffered Tyrode’s albumin-lactate-pyruvate
medium (Sperm TALP) and twice in HEPES/Sperm TALP,
supplemented with 20 mg/ml heparin (IVF TALP). Oocytes of
appropriate morphology were sorted into oil-immersed 80 ml
drops of IVF TALP (,30/drop). Frozen-thawed bovine semen
(Gencor, Guelph, Canada) was prepared by sperm ‘‘swim-up’’ in
Sperm TALP for 1 hr at 38.5uC in a humidified 5% CO2
atmosphere [75]. The upper phase of the sperm/Sperm TALP
solution was centrifuged at 3006g for 5 min to concentrate sperm
in solution. COCs were co-incubated with sperm at a final
concentration of approximately 1.06106 sperm/ml for 18 hr at
38.5uC in a humidified 5% CO2 atmosphere. Fertilization was
concluded by gently vortexing oocytes for 3 min to remove
remaining sperm and cumulus cells. Denuded presumptive zygotes
were washed three times in EmbryoMaxH (Millipore, USA)
synthetic oviductal fluid (SOF) supplemented with 8.0 mg/ml
BSA, 20 ml/L MEM non-essential amino acids, 10 ml/L BME
essential amino acids, 0.4 mM sodium pyruvate and 500 U/ml
Gentamicin. Presumptive zygotes were sorted into oil-immersed
30 ml drops (25 embryos/drop) of supplemented SOF and
incubated in a Sanyo MCO-175M Tri-gas incubator at 38.5uC
in a humidified 90% N2, 5% CO2, 5% O2 atmosphere for up to 8
days (192 hpi) or until further analysis was required.

RNA Interference-mediated Knockdown of p66Shc
The p66Shc specific region (CH2) of the SHC1 gene was
queried for potential RNAi target sequences using the BLOCKitTM RNAi designer software available on the Life TechnologiesTM website (http://rnaidesigner.invitrogen.com/rnaiexpress/).
PLOS ONE | www.plosone.org
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otide and visually assessing the presence of the FITC-oligonucleotides under fluorescence microscopy (Supplemental Figure 1).

conditions that were either obtained from previous studies [78] or
of our novel design (p66Shc) [29]. The 66 kDa isoform - specific
region (CH2) of the homo sapiens SHC1 gene was aligned with
sequenced fragments of the Bos taurus genome (accession #
XM_613898) obtained from the Genbank website (http://www.
ncbi.nlm.nih.gov/sites/entrez?db = nucleotide). Based on sequence alignment, an area exhibiting a high degree of homology
was targeted for oligonucleotide primer design using Primer3
v.0.4.0 software (http://frodo.wi.mit.edu/primer3/; Supplemental
Table S5). To optimize and confirm the specificity of novel
oligonucleotide primers, PCR amplifications were carried out on a
PTC-200 Peltier Thermocycler (MJ Research Inc., USA) utilizing
various temperatures and reaction mixes (Supplemental Table S5).
To each sample the following mixture was added: 10X PCR
buffer, 1.5–3 mmol/L MgCl2, 2.5 mmol/L dNTP mix, 100 pmol
of forward and reverse primers (Supplemental Table S5), 2.5 IU
Ampli Taq GoldTM polymerase (Applied Biosystems, USA), and
PCR-grade water to a final volume of 50 mL. Each product
underwent the following amplification program: activation at
95uC for 10 min, 45 amplification cycles of 95uC for 30 sec,
annealing temperature for 30 sec, elongation at 72uC for 30 sec.
The cycles were followed by a final elongation step at 72uC for
10 min. Aliquots of PCR products were separated by electrophoresis on a 2% agarose gel. The band of the predicted size was
excised and from the gel and purified using QiaquickH Gel
Extraction columns (Qiagen, USA). Aliquots of the extracted PCR
product was run on a subsequent 2% agarose gel along with a low
mass DNA ladder and quantified by comparative densitometry.
The identity of the PCR product was confirmed by having
approximately 20 ng of purified PCR product sequenced by a
DNA Analyzer (Applied Biosystems, USA) at the University of
Guelph Laboratory Services Division.

Hydrogen Peroxide (H2O2) Treatments
Physiological levels of hydrogen peroxide (H2O2) treatment
were employed as a source of exogenous ROS treatment because
of its long physiological half-life (8 hr –20 days) and its ability to
activate p66Shc [27,36,76,77]. Embryos (n = 50, r = 3) were
treated (and non-treated) at various developmental stages (0 hpi,
32 hpi, 48 hpi, 72 hpi) with exogenous H2O2 (50 mM or 100 mM).
In all cases, embryos were transferred into a Nunclon 4-well dish
(Nalge Nunc International) containing 1.0 ml of H2O2-supplemented media and incubated at 38.5uC in a humidified 5% CO2/
5% O2/90% N2 atmosphere for 1 hr. Treated embryos were then
washed twice with and re-suspended in oil-immersed drops of or
SOF medium. Developmental progression was assessed on day 8
(192 hpi). Group size, number of replications, and the timing of
specific quantitative assays (DCF, Real Time PCR, etc.) are
detailed within the results of each experiment.

Total RNA Extraction
Total RNA was extracted from embryos using a combination of
the QiaShredderTM and RNeasyH Micro Kits (Qiagen Inc., USA),
according to the manufacturer’s instructions. Groups (n 350) of
embryos were pooled and homogenized with QiaShredderTM
columns along with 20 ng of poly-A carrier RNA to facilitate
maximum RNA yield. Homogenized samples were then passed
through RNeasyH Micro nucleotide-binding membrane columns.
Following several washes, DNA was eliminated from the columns
via incubation with DNase I for 15 min at room temperature.
Membrane bound RNA was then washed twice and eluted in
14 mL of RNase-free water. The integrity of total RNA was
analyzed via 2% agarose gel electrophoresis. Spectrophometric
measurement of the absorbance at 260 nm and the A260/A280
ratio assessed the purity and yield of total RNA respectively. RNA
samples were used immediately for reverse transcription polymerase chain reaction (RT-PCR) or snap frozen in liquid N2 and
stored at 280uC for future processing.

Real Time (LightCyclerH) PCR
The expressivity of genes of interest was quantified by real-time,
LightCyclerH polymerase chain reaction (LC-PCR) using a
LightCyclerH 1.5 (Roche Applied Science, USA) employing a
Faststart SYBR green I reaction mix (Roche Applied Science,
USA) within 20 mL LightCyclerH glass capillaries. Before gene
transcript quantification, reaction conditions were optimized by
performing LC-PCR runs with and without cDNA template in
order to identify the melting temperatures of potential primerdimers as well as predicted products. Optimized LC-PCR reaction
conditions are described (Supplementary Table S5). The amplification program was as follows: pre-incubation for FastStart
polymerase activation at 95uC for 10 min, 45 amplification cycles
of denaturation at 95uC (20uC/sec) for 10 sec, annealing (20uC/
sec) for 10 sec, elongation at 72uC (5uC/sec) for 20 sec, fluorescent
acquisition (5uC/sec) for 1 sec. Upon the completion of the last
cycle a melting curve was generated by starting the fluorescence
acquisition at 65uC and taking measurements every 0.1uC until
95uC. A standard curve for each target gene was generated using
Purified PCR products quantified through comparative densitometry and divided into six serial dilutions ranging from 16102 pg to
161024 pg of template DNA. Histone 2A (H2A) was amplified in
parallel to genes of interest as an endogenous control for PCR
reaction efficiency. Negative control reactions lacking template
DNA were run in parallel as controls against the formation of
primer-dimers.

Reverse Transcription Polymerase Chain Reaction (RTPCR)
Reverse transcription polymerase chain reaction (RT-PCR) was
performed using the Thermoscript RT-PCR system (InvitrogenTM, USA) according to the manufacturer’s instructions. Eleven
mL of total RNA was combined with 1 mL of 50 mM oligo(dT)20,
and 1 mL of 10 mM dNTP mix. The samples were then denatured
by incubation at 65uC for 5 min and placed on ice, after which the
remainder of the cDNA reaction mixture was added: 4 mL of 5X
cDNA synthesis buffer, 1 mL of 0.1M DTT, 1 mL of RNase OUT
(Life Technologies) and 1 mL of Thermoscript RT (15 U/mL).
The cDNA synthesis reaction was performed on a PTC-200
Peltier Thermocycler (MJ Research Inc., USA) using an incubation at 55uC for 60 min and terminated by a short incubation at
85uC for 5 min. Template RNA was eliminated from the samples
by incubation with 1 mL of E. Coli RNase H (2 U/mL) at 37uC for
20 min. Finally, RT-PCR products were purified using the
QiaquickH PCR Purification Kit (Qiagen, USA) according to the
manufacturer’s instructions. Briefly, the PCR reaction mix was
centrifuged through a DNA-binding column that was washed
several times before the purified DNA was eluted in 30 mL of
PCR-grade water (Sigma-Aldrich Canada, Canada).
Messenger (m)RNA quantification of genes of interest was
accomplished by Real Time PCR utilizing primers and PCR
PLOS ONE | www.plosone.org

Whole Mount Immunofluorescence
Embryos were immuno-stained using fluorophore-conjugated
antibodies for the purpose of protein localization and protein
quantification by measuring immunofluorescent signal intensities.
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adjusted relative signal intensity values, represented in pixels, were
plotted graphically, error bars representing the standard error of
the mean.

An antibody titration series was used to determine the optimum
concentration of each primary and secondary antibody (data not
shown). Antibodies, producers and optimal dilutions are described
in Supplemental Table S6. Embryos were washed twice in PBS at
38.5uC for 5 min and transferred into Fixing Solution (PBS +4%
Paraformaldehyde (PFA)) for a 1 hr incubation at room temperature. Embryos at this point were either processed immediately or
transferred into Embryo Storage Buffer (PBS +1% PFA) for shortterm storage within humidified chambers at 4uC for a period of no
greater than two weeks. Following fixation and/or storage,
embryos were washed three times in PBS at 38.5uC for 5 min
before being blocked and permeabilized simultaneously by
incubation in Embryo Blocking Buffer (PBS +5% normal donkey
serum, 0.01% Triton X-100) for 1 hr at room temperature.
Embryos were then washed in PBS at 38.5uC for 20 min before
being incubated in appropriate primary antibody, under nonsaturating conditions, diluted in Antibody Dilution Buffer/Wash
(PBS +1% normal donkey serum +0.005% Triton X-100) at 4uC
overnight in a humidified chamber. Embryos were washed three
times in Antibody Dilution Buffer/Wash at 38.5uC for 20 min
before incubation in the appropriate secondary antibody diluted in
Antibody Dilution Buffer/Wash within a dark humidified
chamber at 4uC overnight. Under reduced light, embryos were
washed three times in Antibody Dilution Buffer/Wash at 38.5uC
for 45 min, with DAPI (1 mg/mL; 1:2000 dilution, Sigma-Alrich
Canada, Canada) added to the first wash to stain for DNA.
Embryos were mounted on FisherBrandH Glass Slides (Fischer
Scientific, USA) in a drop of DAKO Antifade (DAKO, USA)
covered with No. 1 coverslips (Fischer Scientific, USA) and sealed
with clear nail polish. Slides were imaged using an Olympus
Fluoview Laser Scanning Confocal system on an IX81 inverted
microscope running Olympus Fluoview v.4.3 software. Where
protein quantity was to be determined by immunofluorescent
signal intensity, micrographs of the appropriate fluorescent
channel were converted into greyscale images and inverted
through the black/white axis. Scion Image v.4.03 software was
used to quantify the mean density of the immunofluorescent signal
intensity present in each of the inverted greyscale micrographs.
The mean signal intensity of three negative control micrographs
(without primary antibody incubation) was subtracted from the
measured values of the treatment micrographs to eliminate
background fluorescence. The adjusted relative signal intensity
values, represented in pixels, were plotted graphically, error bars
representing the standard error of the mean.

TUNEL and Propidium Iodide Labelling
The apoptotic status of embryos was assessed through a
combination of terminal deoxynucleotidyl transfer-mediated
dUTP nick-end labelling (TUNEL) and propidium iodide (PI)
nuclear labelling as previously described [80]. TUNEL staining
was achieved using the In Situ Cell Death Detection Kit (Roche
Applied Science, USA). Embryos were collected and washed three
times in PBS/PVA and fixed with 4% PFA in PBS for 1 hr at
room temperature. Fixed embryos were permeabilized in 0.5%
Triton X-100 (Biorad Laboratories Ltd, Canada) in PBS for 1 hr
at room temperature. Permeabilized embryos were incubated in
the TUNEL mixture (deoxynucleotidyl transferase enzyme and
fluorescein-dUTP in a 1:9 ratio) for 1 hr at 37uC in the dark.
Positive control embryos were pre-incubated with 5 IU DNase I
(Promega, USA) for 20 min at 37uC. Negative control embryos
were incubated in fluorescein-dUTP in the absence of the
transferase enzyme. Embryos were then washed twice in 0.5%
Triton X-100 in PBS, once in PBS/PVA and once in RNase
buffer (40 mM Tris, 10 mM NaCl, 6 mM MgCl2, pH 8.0) before
incubation with 0.1 mg/ml of RNase (Sigma-Aldrich) for 1 hr at
37uC in the dark. Following two washes in RNase buffer, the
nuclei were stained with 5 mg/ml PI for 45 min at 37uC in the
dark. Lastly, embryos were washed twice in PBS-PVA and
mounted on slides with a 0.2% agar PBS solution. Stained
embryos were imaged using an Olympus BX61 epifluorescence
microscope running MetaMorphTM image analysis software.
Embryos were considered to be apoptotic if .50% of stained
nuclei exhibited fragmented and condensed morphology by PI
staining in addition to positive TUNEL staining [81].

Statistical Analysis
After homogeneity of variance of each sample was confirmed,
statistical analysis was performed using the post-hoc TukeyKramer test [82]. Data were represented as means 6 SEM.
Differences between means were considered statistically significant
when P,0.05.

Supporting Information
Figure S1 Microinjection of FITC-labeled oligonucleo-

tide probes into bovine zygotes.
(DOCX)

Dichlorofluorescein (DCF) Staining
Embryo H2O2 levels were quantified using the fluorescent
probe 6-carboxy-2,7-dichlorodihydrofluorescein diacetate (DCF)
(Molecular Probes) [79]. A stock solution of 5 mM DCF dissolved
in DMSO (Sigma-Aldrich Canada, Canada) was diluted in PBS to
a working concentration of 5 mM. Embryos were washed twice in
PBS and placed 1271 into a Nunclon 4-well dish (Nalge-Nunc,
USA) containing 500 mL of 5 mM DCF. Embryos were incubated
at 38.5uC in a dark, humidified 90% N2, 5% CO2, 5% O2
atmosphere for 30 min. Stained embryos were washed twice with
fresh PBS, sorted into a 72-well Microwell Minitray (Nalge Nunc
International, USA) containing 10 mL of PBS and imaged
(excitation at 495 nm and emission at 520 nm) using an Olympus
IX81 inverted microscope capable of live-cell imaging. Image Pro
Plus 5.0 image analyzing software was used to quantify the
fluorescent signal intensity. The mean signal intensity of three
negative control micrographs (embryos fixed with 4% PFA prior to
DCF staining) was subtracted from the measured values of the
treatment micrographs to eliminate background DCF signal. The
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Real-time quantification of p66Shc mRNA
levels at various developmental timepoints after siRNA
injection of bovine zygotes.
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Figure S2

Figure S3 Quantification of Serine 36-phosphorylatedp66Shc protein following RNAi-mediated knockdown of
p66Shc.
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Figure S4 Localization of FOXO3a protein by immunofluorescent confocal microscopy.
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Real-time PCR quantification of Catalase and
MnSOD mRNA following RNAi-mediated knockdown of
p66Shc.
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Figure S5
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Figure S6 Quantification of Catalase protein levels

Table S5 Summary of oligonucleotide primers and PCR
conditions utilized.
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following RNAi-mediated knockdown of p66Shc.
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Table S6 Summary information on the primary anti-
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Table S2 Microinjection efficacy of optimized settings
for siRNA delivery.
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